243 related articles for article (PubMed ID: 23249221)
1. Study of the quantitative, functional, cytogenetic, and immunoregulatory properties of bone marrow mesenchymal stem cells in patients with B-cell chronic lymphocytic leukemia.
Pontikoglou C; Kastrinaki MC; Klaus M; Kalpadakis C; Katonis P; Alpantaki K; Pangalis GA; Papadaki HA
Stem Cells Dev; 2013 May; 22(9):1329-41. PubMed ID: 23249221
[TBL] [Abstract][Full Text] [Related]
2. Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival.
Trimarco V; Ave E; Facco M; Chiodin G; Frezzato F; Martini V; Gattazzo C; Lessi F; Giorgi CA; Visentin A; Castelli M; Severin F; Zambello R; Piazza F; Semenzato G; Trentin L
Oncotarget; 2015 Dec; 6(39):42130-49. PubMed ID: 26517523
[TBL] [Abstract][Full Text] [Related]
3. Reserves, functional, immunoregulatory, and cytogenetic properties of bone marrow mesenchymal stem cells in patients with myelodysplastic syndromes.
Klaus M; Stavroulaki E; Kastrinaki MC; Fragioudaki P; Giannikou K; Psyllaki M; Pontikoglou C; Tsoukatou D; Mamalaki C; Papadaki HA
Stem Cells Dev; 2010 Jul; 19(7):1043-54. PubMed ID: 19788374
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival.
Corradi G; Baldazzi C; Očadlíková D; Marconi G; Parisi S; Testoni N; Finelli C; Cavo M; Curti A; Ciciarello M
Stem Cell Res Ther; 2018 Oct; 9(1):271. PubMed ID: 30359303
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stromal cells derived from the bone marrow of acute lymphoblastic leukemia patients show altered BMP4 production: correlations with the course of disease.
Vicente López Á; Vázquez García MN; Melen GJ; Entrena Martínez A; Cubillo Moreno I; García-Castro J; Orellana MR; González AG
PLoS One; 2014; 9(1):e84496. PubMed ID: 24400095
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells contribute to the abnormal bone marrow microenvironment in patients with chronic idiopathic neutropenia by overproduction of transforming growth factor-β1.
Stavroulaki E; Kastrinaki MC; Pontikoglou C; Eliopoulos D; Damianaki A; Mavroudi I; Pyrovolaki K; Katonis P; Papadaki HA
Stem Cells Dev; 2011 Aug; 20(8):1309-18. PubMed ID: 21047210
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
[TBL] [Abstract][Full Text] [Related]
8. Exosomes derived from chronic lymphocytic leukaemia cells transfer miR-146a to induce the transition of mesenchymal stromal cells into cancer-associated fibroblasts.
Yang Y; Li J; Geng Y
J Biochem; 2020 Nov; 168(5):491-498. PubMed ID: 32770182
[TBL] [Abstract][Full Text] [Related]
9. The chronic lymphocytic leukemia clone disrupts the bone marrow microenvironment.
Janel A; Dubois-Galopin F; Bourgne C; Berger J; Tarte K; Boiret-Dupré N; Boisgard S; Verrelle P; Déchelotte P; Tournilhac O; Berger MG
Stem Cells Dev; 2014 Dec; 23(24):2972-82. PubMed ID: 25055118
[TBL] [Abstract][Full Text] [Related]
10. Bone Marrow Lymphoid Niche Adaptation to Mature B Cell Neoplasms.
Dumontet E; Mancini SJC; Tarte K
Front Immunol; 2021; 12():784691. PubMed ID: 34956214
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal Stem/Stromal Cells Derived from Dental Tissues: A Comparative In Vitro Evaluation of Their Immunoregulatory Properties Against T cells.
De la Rosa-Ruiz MDP; Álvarez-Pérez MA; Cortés-Morales VA; Monroy-García A; Mayani H; Fragoso-González G; Caballero-Chacón S; Diaz D; Candanedo-González F; Montesinos JJ
Cells; 2019 Nov; 8(12):. PubMed ID: 31766697
[TBL] [Abstract][Full Text] [Related]
12. Extracellular vesicles of bone marrow stromal cells rescue chronic lymphocytic leukemia B cells from apoptosis, enhance their migration and induce gene expression modifications.
Crompot E; Van Damme M; Pieters K; Vermeersch M; Perez-Morga D; Mineur P; Maerevoet M; Meuleman N; Bron D; Lagneaux L; Stamatopoulos B
Haematologica; 2017 Sep; 102(9):1594-1604. PubMed ID: 28596280
[TBL] [Abstract][Full Text] [Related]
13. Anti-leukemic therapies induce cytogenetic changes of human bone marrow-derived mesenchymal stem cells.
Yeh SP; Lo WJ; Lin CL; Liao YM; Lin CY; Bai LY; Liang JA; Chiu CF
Ann Hematol; 2012 Feb; 91(2):163-72. PubMed ID: 21573981
[TBL] [Abstract][Full Text] [Related]
14. Human olfactory mucosa multipotent mesenchymal stromal cells promote survival, proliferation, and differentiation of human hematopoietic cells.
Diaz-Solano D; Wittig O; Ayala-Grosso C; Pieruzzini R; Cardier JE
Stem Cells Dev; 2012 Nov; 21(17):3187-96. PubMed ID: 22471939
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stromal cells derived from acute myeloid leukemia bone marrow exhibit aberrant cytogenetics and cytokine elaboration.
Huang JC; Basu SK; Zhao X; Chien S; Fang M; Oehler VG; Appelbaum FR; Becker PS
Blood Cancer J; 2015 Apr; 5(4):e302. PubMed ID: 25860293
[TBL] [Abstract][Full Text] [Related]
16. Excessive production of transforming growth factor-beta by bone marrow stromal cells in B-cell chronic lymphocytic leukemia inhibits growth of hematopoietic precursors and interleukin-6 production.
Lagneaux L; Delforge A; Dorval C; Bron D; Stryckmans P
Blood; 1993 Oct; 82(8):2379-85. PubMed ID: 7691258
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro.
Bocelli-Tyndall C; Bracci L; Spagnoli G; Braccini A; Bouchenaki M; Ceredig R; Pistoia V; Martin I; Tyndall A
Rheumatology (Oxford); 2007 Mar; 46(3):403-8. PubMed ID: 16920750
[TBL] [Abstract][Full Text] [Related]
18. Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells.
Pelizzo G; Veschi V; Mantelli M; Croce S; Di Benedetto V; D'Angelo P; Maltese A; Catenacci L; Apuzzo T; Scavo E; Moretta A; Todaro M; Stassi G; Avanzini MA; Calcaterra V
BMC Cancer; 2018 Nov; 18(1):1176. PubMed ID: 30482160
[TBL] [Abstract][Full Text] [Related]
19. Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis.
Larghero J; Farge D; Braccini A; Lecourt S; Scherberich A; Foïs E; Verrecchia F; Daikeler T; Gluckman E; Tyndall A; Bocelli-Tyndall C
Ann Rheum Dis; 2008 Apr; 67(4):443-9. PubMed ID: 17526552
[TBL] [Abstract][Full Text] [Related]
20. Microenvironmental stromal cells abrogate NF-κB inhibitor-induced apoptosis in chronic lymphocytic leukemia.
Simon-Gabriel CP; Foerster K; Saleem S; Bleckmann D; Benkisser-Petersen M; Thornton N; Umezawa K; Decker S; Burger M; Veelken H; Claus R; Dierks C; Duyster J; Zirlik K
Haematologica; 2018 Jan; 103(1):136-147. PubMed ID: 29122993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]